Name Funds holding
in top 10
Growth Growth % Return since
31 Mar ‘25
1201
1 -1 -50% 23.8%
1202
1 -1 -50% 20.5%
1203
1 -1 -50% 900%
DNLI icon
1204
Denali Therapeutics
DNLI
$2.86B
1 -1 -50% 43.2%
1205
1 -1 -50% 30.1%
1206
1 -1 -50% 27.1%
1207
2 -2 -50% 1.18%
1208
2 -2 -50% 43.1%
1209
2 -2 -50% 98.4%
1210
2 -2 -50% 17.9%
CALX icon
1211
Calix
CALX
$3.66B
2 -2 -50% 56%
1212
2 -2 -50% 85.9%
1213
2 -2 -50% 18.3%
1214
3 -3 -50% 46.1%
1215
3 -3 -50% 40.4%
1216
3 -3 -50% 16.3%
1217
3 -3 -50% 0.78%
1218
3 -3 -50% 51.9%
1219
3 -3 -50% 33.2%
1220
3 -3 -50% 2.77%
1221
4 -4 -50% 5.07%
1222
4 -4 -50% 23.4%
1223
4 -4 -50% 253%
1224
4 -4 -50% 120%
1225
4 -4 -50% 45.9%